Sanofi (SNY)

Sanofi Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	3,499	4,977	5,554	5,098	8,083	6,279
Depreciation & Amortization	4,789	5,678	3,586	4,429	3,108	3,351
Stock-Based Compensation	227.5	313	278	260	234	244
Other Adjustments	-4,068	-5,224	-3,570	-3,547	-3,651	-2,370
Change in Receivables	-809.5	-1,202	-28	-472	-500	185
Changes in Inventories	278.5	-39	-477	-866	-918	-357
Changes in Accounts Payable	304.5	398	789	258	340	451
Changes in Other Operating Activities	2,332	2,827	-425	2,480	1,172	1,130
Operating Cash Flow	10,340	10,750	9,081	10,258	10,526	10,522
Operating Cash Flow Growth	-6.73%	18.38%	-11.47%	-2.55%	0.04%	106.76%
Capital Expenditures	-2,828	-3,538	-3,195	-2,906	-2,103	-2,043
Sale of Property, Plant & Equipment	630	847	1,461	807	1,340	676
Purchases of Investments	-472.5	-684	-623	-134	-487	-311
Payments for Business Acquisitions	-9,125	-9,394	-1,901	-2,535	-987	-5,594
Proceeds from Business Divestments	-	-	-	42	134	42
Other Investing Activities	4,791	10,322	-149	-1,474	28	-68
Investing Cash Flow	-3,949	-2,447	-4,407	-6,200	-2,075	-7,298
Short-Term Debt Issued	-2,761	-1,100	59	751	216	-414
Net Short-Term Debt Issued (Repaid)	-2,761	-1,100	59	751	216	-414
Long-Term Debt Issued	4,063	5,559	-	48	1,549	-
Long-Term Debt Repaid	-1,964	-2,955	-953	-3,936	-2,998	-2,390
Net Long-Term Debt Issued (Repaid)	2,099	2,604	-953	-3,888	-1,449	-2,390
Issuance of Common Stock	162.5	177	187	195	188	186
Repurchase of Common Stock	-3,029	-5,030	-302	-593	-497	-382
Net Common Stock Issued (Repurchased)	-2,866	-4,853	-115	-398	-309	-196
Other Financing Activities	-40	-48	-12	-7	-14	-
Financing Cash Flow	-9,142	-8,207	-5,763	-8,052	-5,821	-7,056
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-18	-47	-13	-32	8	15
Net Cash Flow	-2,447	216	-1,269	-4,026	2,638	-3,817
Free Cash Flow	7,512	7,212	5,886	7,352	8,423	8,479
Free Cash Flow Growth	4.16%	22.53%	-19.94%	-12.72%	-0.66%	182.07%
FCF Margin	15.86%	15.44%	13.29%	17.67%	20.77%	21.64%
Free Cash Flow Per Share	3.10	2.94	2.34	2.93	3.35	3.37
Levered Free Cash Flow	11,768	14,643	4,944	5,658	8,737	5,951
Unlevered Free Cash Flow	10,046	10,599	6,226	9,223	9,809	9,034

Updated Apr 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q